Latest news for Cardiff Lexington (OTC:CDIX) Stock

Cardiff Lexington Corp is an acquisition holding company focused on locating undervalued and undercapitalized companies, primarily in the healthcare industry, and providing them capitalization and leadership to maximize the value and potential of their private enterprises while also providing diversification and risk mitigation for its stockholders. It has two reportable operating segments; Healthcare (Nova), and Real Estate (Edge View). The healthcare segment provides a full range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. The real estate segment consists of Edge View, a real estate company that owns five (5) acres zoned medium-density residential.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AAWW

ABBV

ABEO

ACER

ACGBF

ACGBY

ACOR

ACRGF

ACRS

ADAP

ADBCF

ADPT

AGDXF

AGIO

AHKSY

AKBA

AKCA

ALDR

ALFVF

ALFVY

ALNA

ALTM

ALTPF

ALXEF

AMCR

AMGDF

AMRX

ANAB

ANDE

APAFF

APEN

APNHF

APNHY

AQST

ARCH

AREVF

ARGGY

ASGLY

ASMB

ASNA

ASRT

ATRA

AVGR

AVLIF

AWRE

AXAS

AXION VENTURES INC by Axion Ventures Inc.

AXNVF

BACHF

BACHY

BAFYY

BASFY

BBBY

BBVA

BBVXF

BCDA

BCEL

BEDU

BELFA

BFIN

BICEY

BIDU

BJCHF

BLCM

BLMN

BNFT

BNKHF

BORR

BOXS

BRKMY

BRVRF

BSET

BrightSphere Investment Group plc Ordinary Shares

BSIG

BVTEF

BXEFF

BZLFY

CADE

CALX

CAMP

CANL

New 52-Week Lows For Monday Morning

CARDIFF LEXINGTN CORP by Cardiff Lexington Corporation

Cardiff Lexington Corp

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is set to make its return to the Paris Motor Show in October, adding to an exciting month for the electric vehicle sector and investors headlined by the<a href="https://www.benzinga.com/news/24/09/40808924/tesla-robotaxi-event-to-be-held-in-los-angeles-on-1010-says-senior-company-exec-existing-shareholder"> company's robotaxi day.</a>
What Happened: Over the years, Tesla missed out on attending the event, the Le Parisien Journal <a href="https://www.leparisien.fr/automobile/mondial-de-lauto-2024-tesla-fait-son-grand-retour-au-salon-parisien-22-09-2024-BHN42HCPF5DSRB2XC2PWIYLG7M.php">reports</a>.
"Like a World Cup without Brazil," a visitor at the 2022 Paris Motor Show previously said.
This year, Tesla is expected to attend the event, which is being held from Oct. 14 to Oct. 20 at the Porte de Versailles. 
The Austin, Texas-based company is expected to showcase multiple vehicle models, including the Model S, 3, X and Y and the recently launched Cybertruck.
Launched in November 2023, the Cybertruck is one of the most anticipated vehicles of all time and has a long wait list. While the vehicle is not yet available to drive in France, the vehicle's presence at the auto show will likely be one of the most talked items from the Paris Motor Show, the report said.
"Attendees will also be able to discover our charging stations, with the most extensive charging network in the world," Tesla said, according to the report.
Tesla will also highlight its Tesla Energy segment during the motor show, which could include highlights like solar roofs and Powerwall energy solutions.
Along with its vehicles, Tesla is also expected to have its Optimus humanoid robot on hand.
Tesla CEO Elon Musk is not expected to attend but could be featured in a virtual presentation.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent092524">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: Tesla's appearance at the auto show in October adds to an exciting month for the electric vehicle giant.
The company hosts its Robotaxi Day on Oct. 10. Tesla will also report third-quarter vehicle production and delivery figures at the beginning of October and is expected to report third-quarter financial results during the month as well.
Tesla last attended the Paris Motor Show in 2018 and presented its Model 3 vehicle. The electric vehicle company has grown significantly since that time and now has multiple vehicles to show off.
The appearance of the Cybertruck and Optimus could be highlights as Tesla makes infrequent appearances at auto shows.
In September, Tesla <a href="https://www.benzinga.com/news/23/09/34332610/tesla-back-at-detroit-auto-show-after-8-years-will-musk-show-up">attended the Detroit Auto Show</a> for the first time in eight years. Similar to the Paris Motor Show, Tesla's last appearance at that auto show came before several of its key vehicles were released.
TSLA Price Action: Tesla stock is down 1% to $254.27 on Tuesday versus a 52-week trading range of $138.80 to $271.00. Tesla stock is up 2% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39918390/tesla-q2-earnings-highlights-revenue-beat-eps-miss-robotaxi-update-2024-growth-rate-to-be-notably-l">Tesla Q2 Earnings Highlights: Revenue Beat, EPS Miss, Robotaxi Update, 2024 Growth Rate To Be &#8216;Notably Lower&#8217; Than 2023</a></li>
</ul>
Image: Courtesy of Tesla

TSLA

Tesla Returns To Paris Motor Show For First Time In 6 Years: Cybertruck To Be Featured, Will Elon Musk Present?

DA Davidson analyst Gil Luria maintains Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) with a Neutral and raises the price target from $250 to $300.

Price Target

Analyst Ratings

MNDY

DA Davidson Maintains Neutral on Monday.Com, Raises Price Target to $300

<h3>Gainers</h3>
<ul>
<li>Genius Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) shares moved upwards by 20.1% to $1.04 during Wednesday's regular session. The market value of their outstanding shares is at $22.5 million. </li>
<li>Pinstripes Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNST#NYSE">PNST</a>) shares rose 16.07% to $0.74. The market value of their outstanding shares is at $37.8 million. </li>
<li>Twin Vee PowerCats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>) stock rose 11.87% to $0.62. The company's market cap stands at $5.9 million. </li>
<li>Charles &amp; Colvard (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTHR#NASDAQ">CTHR</a>) stock moved upwards by 11.37% to $1.91. The company's market cap stands at $5.8 million. </li>
<li>iRobot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRBT#NASDAQ">IRBT</a>) stock increased by 9.11% to $8.37. The company's market cap stands at $240.6 million. </li>
<li>Gogoro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GGR#NASDAQ">GGR</a>) shares increased by 8.16% to $0.56. The company's market cap stands at $183.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Stitch Fix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFIX#NASDAQ">SFIX</a>) stock fell 33.3% to $2.5 during Wednesday's regular session. The market value of their outstanding shares is at $305.8 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Target Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TH#NASDAQ">TH</a>) stock fell 18.44% to $7.7. The market value of their outstanding shares is at $773.3 million. </li>
<li>SRIVARU Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVMH#NASDAQ">SVMH</a>) stock decreased by 11.79% to $0.08. The market value of their outstanding shares is at $3.1 million. </li>
<li>Fenbo Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEBO#NASDAQ">FEBO</a>) shares fell 11.24% to $4.98. The market value of their outstanding shares is at $55.0 million. </li>
<li>Interactive Strength (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) shares declined by 10.81% to $0.23. The market value of their outstanding shares is at $1.2 million. </li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) stock fell 8.68% to $4.63. The company's market cap stands at $7.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTHR

FEBO

IRBT

MULN

PNST

SFIX

SVMH

TRNR

VEEE

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares increased by 28.2% to $5.16 during Wednesday's regular session. The company's market cap stands at $2.9 million. </li>
<li>Bone Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>) shares rose 26.07% to $2.74. The market value of their outstanding shares is at $4.9 million. </li>
<li>CERo Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) stock moved upwards by 20.59% to $0.11. The company's market cap stands at $5.8 million. </li>
<li>Capricor Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>) stock increased by 19.78% to $10.9. The market value of their outstanding shares is at $385.1 million. </li>
<li>Corbus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) stock increased by 14.51% to $21.0. The company's market cap stands at $252.9 million. </li>
<li>Eterna Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERNA#NASDAQ">ERNA</a>) shares increased by 12.7% to $1.27. The market value of their outstanding shares is at $6.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) shares declined by 15.6% to $0.14 during Wednesday's regular session. The market value of their outstanding shares is at $4.1 million. </li>
<li>Senti Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) stock fell 12.97% to $2.55. The market value of their outstanding shares is at $11.6 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares declined by 11.66% to $2.88. The company's market cap stands at $4.6 million. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) shares fell 10.74% to $0.48. The market value of their outstanding shares is at $1.3 million. </li>
<li>Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) shares decreased by 10.65% to $19.84. The market value of their outstanding shares is at $1.7 billion. </li>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) shares declined by 10.64% to $0.41. The market value of their outstanding shares is at $3.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBLG

CAPR

CERO

CRBP

ERNA

FTRE

OGEN

SNTI

STSS

TNON

VTAK

WINT

12 Health Care Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>KULR Tech Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) stock increased by 15.1% to $0.29 during Wednesday's regular session. The company's market cap stands at $56.0 million. </li>
<li>Momentus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTS#NASDAQ">MNTS</a>) shares moved upwards by 13.03% to $0.56. The market value of their outstanding shares is at $14.3 million. </li>
<li>Rocket Lab USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) shares rose 12.38% to $8.53. The market value of their outstanding shares is at $4.2 billion. </li>
<li>Quhuo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QH#NASDAQ">QH</a>) stock rose 10.2% to $1.51. The market value of their outstanding shares is at $135.4 million. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATIF#NASDAQ">ATIF</a>) stock increased by 9.9% to $1.22. The company's market cap stands at $14.5 million. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) stock moved upwards by 9.87% to $1.55. The company's market cap stands at $48.6 million. The company's, Q4 earnings came out 4 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BlackSky Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NYSE">BKSY</a>) stock decreased by 20.0% to $4.03 during Wednesday's regular session. The market value of their outstanding shares is at $75.0 million. </li>
<li>Expion360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPON#NASDAQ">XPON</a>) stock fell 11.09% to $0.08. The company's market cap stands at $4.3 million. </li>
<li>ConnectM Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTM#NASDAQ">CNTM</a>) shares decreased by 10.31% to $1.13. The company's market cap stands at $28.1 million. </li>
<li>Nano Nuclear Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) shares declined by 7.04% to $12.81. The market value of their outstanding shares is at $385.9 million. </li>
<li>Safe Pro Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPAI#NASDAQ">SPAI</a>) shares fell 6.98% to $2.73. The market value of their outstanding shares is at $37.9 million. </li>
<li>Zeo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) stock declined by 6.79% to $2.55. The company's market cap stands at $14.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATIF

BlackSky Technology Inc. Class A Common Stock

BKSY

CNTM

KULR

MNTS

RKLB

SPAI

XPON

12 Industrials Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Cipher Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) stock increased by 18.8% to $4.09 during Wednesday's regular session. The company's market cap stands at $1.3 billion. </li>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) stock rose 16.83% to $0.25. The company's market cap stands at $1.9 million. </li>
<li>Alpha Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGL#NASDAQ">ATGL</a>) stock moved upwards by 16.79% to $1.69. The company's market cap stands at $25.7 million. </li>
<li>CISO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) shares rose 13.73% to $0.65. The company's market cap stands at $7.6 million. </li>
<li>Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) stock moved upwards by 13.13% to $8.01. The market value of their outstanding shares is at $1.7 billion. </li>
<li>Wrap Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRAP#NASDAQ">WRAP</a>) stock moved upwards by 12.93% to $1.61. The market value of their outstanding shares is at $74.0 million. As per the press release, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Banzai International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNZI#NASDAQ">BNZI</a>) stock decreased by 25.1% to $6.17 during Wednesday's regular session. The company's market cap stands at $5.9 million. </li>
<li>Intchains Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) shares decreased by 14.37% to $8.7. The company's market cap stands at $522.1 million. </li>
<li>Gorilla Tech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) shares fell 8.83% to $3.99. The company's market cap stands at $44.3 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock decreased by 6.83% to $0.09. The market value of their outstanding shares is at $2.9 million. </li>
<li>GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) stock decreased by 6.62% to $20.11. The market value of their outstanding shares is at $3.9 billion. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) shares decreased by 6.39% to $0.49. The company's market cap stands at $8.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APLD

ATGL

BNZI

CIFR

CISO

GRRR

MLGO

SOBR

WRAP

12 Information Technology Stocks Moving In Wednesday's Intraday Session

Canaccord Genuity analyst Maria Ripps maintains Stitch Fix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFIX#NASDAQ">SFIX</a>) with a Hold and lowers the price target from $4.5 to $3.5.

Canaccord Genuity Maintains Hold on Stitch Fix, Lowers Price Target to $3.5

<a href="https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-announces-crackdown-deceptive-ai-claims-schemes" title="https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-announces-crackdown-deceptive-ai-claims-schemes">https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-announces-crackdown-deceptive-ai-claims-schemes</a>

Macro Notification

FTC Launches Operation AI Comply, Cracking Down On Deceptive AI Claims And Schemes With Five Law Enforcement Actions Targeting Misleading AI Practices

Macquarie analyst Tim Nollen reiterates AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) with a Outperform and raises the price target from $115 to $150.

Reiteration

Macquarie Reiterates Outperform on AppLovin, Raises Price Target to $150

Last Thursday, Darden Restaurants Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dri#NYSE">DRI</a>) issued weaker than expected fiscal first quarter earnings as fine dining restaurants and Olive Garden struggled with lower sales.&nbsp;
Fiscal first quarter highlights show summer sales fell short of expectations.
For the quarter ended on August 25th, Darden reported revenue grew 1% YoY to&nbsp;$2.76 billion, coming short of LSEG&rsquo;s consensus estimate of $2.8 billion, but same store sales declined 1.1%. Like its restaurant peers, Darden&rsquo;s traffic struggled during summer, presumably due to increased travel. Moreover, Olive Garden reported that same-store sales contracted by 2.9% while fine dining suffered an even sharper drop of 6%. The only chain to report sales growth was LongHorn Steakhouse, with an increase of 3.7%. Net income rose from last year&rsquo;s comparable quarter to $207.2 million, or $1.74 per share. Excluding costs brought on by July&rsquo;s acquisition of Chuy&rsquo;s, adjusted earnings amounted to $1.75 per share.
<h3>Outlook</h3>
Darden expects the Chuy&rsquo;s deal to close during the current, fiscal second, quarter. This is also when the results of its second acquisition in two years, Ruth&rsquo;s Chris Steak House will appear in its same-store sales figures.
Despite a challenging quarter, Darden reaffirmed its fiscal 2025-year guidance. For the full fiscal year, Darden guided for net sales in the range between $11.8 billion and $11.9 billion, with earnings from continuous operations ranging from $9.40 to $9.60 per share.&nbsp;
Despite a gloomy quarter, CEO Rick Cardenas&nbsp;has not lost confidence.
While acknowledging that results were below expectations, Cardenas is confident that the initiatives that the company took to boost its revenue and address their guests&rsquo; needs, including its first partnership with Uber Technologies Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uber#NYSE">UBER</a>), will bring the desired improvements shortly, without damaging the long-term picture. With the two-year exclusive deal with Uber, Darden ended its resistance to third-party delivery, something it wasn&rsquo;t willing to give up even during the pandemic times during which Uber thrived. In an effort to lure back customers, Olive Garden will be bringing back its &lsquo;Never Ending Pasta Bowl&rsquo; promotion a month earlier than usual, along with a three-week extension compared to last year. Like its industry peers, Darden is adjusting to a challenging macroenvironment with value promotions, menu revamping and strategic partnerships. Here&#39;s to hoping that Uber will help Darden to boost its sales and that the summer slump was just a blip.&nbsp;
DISCLAIMER: This content is for informational purposes only. It is not intended as investing advice.
This article is from an unpaid external contributor. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

Restaurants

UBER

Darden Restaurants' Business Confidence Remains Intact Despite Summer Slump

Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>) with a Buy and raises the price target from $236 to $269.

PODD

Canaccord Genuity Maintains Buy on Insulet, Raises Price Target to $269

WIIM

AMGN

Amgen shares are trading lower after following atopic dermatitis data, which some analysts noted did not meet expectations amid competition in the market.

Canaccord Genuity analyst William Plovanic maintains iRhythm Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) with a Buy and raises the price target from $122 to $137.

IRTC

Canaccord Genuity Maintains Buy on iRhythm Technologies, Raises Price Target to $137

SBC Medical Group Shares Resume Trade

On Wednesday, Emergent BioSolutions Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) said it secured approximately $400 million in orders in 2024 and 2025 associated with its vaccinia, smallpox, and <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g41021297/emergent-biosolutions-confirms-approximately-400-million-in-orders-in-2024-2025-to-support-smallpo" rel="noreferrer noopener">mpox product portfolio</a>.
What Happened: The order includes the previously disclosed&nbsp;U.S. government contract modification&nbsp;to procure ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live), as well as CNJ-016&nbsp;[Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) contract options exercised <a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/39602092/why-is-vaccine-maker-emergent-biosolutions-stock-trading-higher-on-tuesday" rel="noreferrer noopener">in&nbsp;2023&nbsp;and&nbsp;2024</a>.
To date, in 2024, nearly $210 million in customer orders have been delivered for ACAM2000&nbsp;and VIGIV.
For the remainder of 2024 and into 2025, Emergent is confirmed to deliver more than $185 million in ACAM2000 and VIGIV orders.
&#8220;Emergent continues to be a trusted partner to supply medical countermeasures for biodefense and global health preparedness, and these incremental orders demonstrate our ongoing leadership to help address serious viral threats like smallpox and mpox,&#8221; said Joe Papa, president and CEO of Emergent.
Why It Matters: In August, the FDA approved Emergent BioSolutions&#8217; supplemental Biologics License Application (sBLA)&nbsp;to expand the indication for ACAM2000 to include preventing mpox disease in individuals at high&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40649541/mpox-vaccine-emergent-biosolutions-smallpox-vaccine-gets-fda-nod-for-expanded-use-for-individuals" rel="noreferrer noopener">risk for mpox infection</a>.
Shortly after, Emergent&nbsp;<a target="_blank" href="https://www.globenewswire.com/Tracker?data=EzQNYDD8pjtoG0gZzPCrG3pNpuayyfCXiLNpEwRuNQeXZCSjZPieHKbrFjIlQ6LthEsBPtCl2YoAr32DdkOrKgYmRck1tI9jw9Csclvb-DBrRN4ZcsnFimIlLvkIVTA7OMfhLX9Rz8PWUS6XTJRHZuvZv7FyFwtw1_p3I81lKppGQdmnoDbE1M1s2YOZlkfiobjdbi5T98mDUJI7CFCLnS-nY2jaaMEOuKWt-LKaI1g_E83TYZBq7F4mtGkYFfb026H5va42kZ2TP7mEmKP1aKHST2zxTD8uCiP51PpIG-38SyuoKHWlnseAJyL1HaG2poVAmXYZE9hDFMC9HVwRyLAsSMnZy3Mvv9v1Y5mCnq-ToHmuQfXCWDrekdJu5ywMj7CrT5OghPd5H2abWQMrZN0Jz5oizAyZlsfW8jrDxXY=" rel="noreferrer noopener">announced</a> that it submitted an Expression of Interest for the ACAM2000 vaccine to be assessed for Emergency Use Listing (EUL) with the&nbsp;World Health Organization&nbsp;(WHO).
In furtherance of its commitment to support mpox response efforts,&nbsp;Emergent has donated 50,000 doses of ACAM2000 for potential deployment across impacted countries across the African continent.
Last month, Emergent BioSolutions reported second-quarter 2024 sales of $254.7 million, down 25% year over year, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40226161/vaccine-maker-emergent-biosolutions-expects-deeper-losses-in-2024-stock-sinks" rel="noreferrer noopener">consensus of $190 million</a>.
The company reported an adjusted EPS loss of $(2.32), more than double the $(1.05) reported a year ago,&nbsp;missing the consensus of $(0.94).
Emergent BioSolutions updated its 2024 Revenue guidance from $1 billion—$1.1 billion to $1.05 billion—$1.125 billion, versus the consensus of $1.03 billion.
Price Action: EBS stock is down 3.7% at $5.88 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/09/41024832/eli-lilly-touts-results-of-eu-approved-dermatitis-treatment-shows-sustained-disease-control-for-u" target="_blank" rel="noreferrer noopener">Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years</a>.</li>
</ul>
Photo: Unsplash

Biotech

Government

Health Care

Contracts

Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines

Merging of Nano Dimension with Desktop Metal and Markforged Will Have the Scale and Capital to Drive to Profitable Expansion With a Combined 2023 Revenue of $340M &nbsp;
Cash &amp; Cash Equivalents Expected at Close of ~$475M
The Combined Company Further Increases Value Creation Opportunity With an Even Broader AM/3D Printing Portfolio Technologies Intended for True Manufacturing Applications
Nano Dimension and Markforged to Hold Joint Investor Call to Discuss the Transaction Tomorrow, Thursday, September 26th, at 8:30 AM ET
WALTHAM, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNDM#NASDAQ">NNDM</a>) ("Nano Dimension") and Markforged Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKFG#NYSE">MKFG</a>) ("Markforged") today jointly announced that they have entered into a definitive agreement pursuant to which Nano Dimension will acquire all outstanding shares of Markforged in an all-cash transaction for $5.00 per share.
In acquiring Markforged, Nano Dimension is acquiring a company with scale and efficiency. Markforged's 2023 revenue was $93.8 million with a 47.4% gross margin and 48.6% non-GAAP gross margin, and a second quarter of 2024 gross margin of 48.3% and non-GAAP gross margin of 51.9%, with potential to expand further. The combined company post-closing, including both Desktop Metal and Markforged, is expected to have a strong balance sheet with a total expected cash &amp; cash equivalents, which includes marketable securities, of $475 million.

MKFG

NNDM

Nano Dimension And Markforged Have Entered Into A Definitive Agreement Pursuant To Which Nano Dimension Will Acquire All Outstanding Shares Of Markforged In An All-Cash Transaction For $5.00 Per Share; Will Have The Scale And Capital To Drive To Profitable Expansion With A Combined 2023 Revenue Of $340M; Cash & Cash Equivalents Expected At Close Of ~$475M

Macro Economic Events

Econ #s

Economics

USA Gasoline Inventories A Draw Of 1.538M	Vs A Build Of 0.200M Est.;	Build Of 0.069M Prior

Financial giants have made a conspicuous bullish move on PDD Holdings. Our analysis of options history for PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) revealed 22 unusual trades.
Delving into the details, we found 45% of traders were bullish, while 31% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $404,941, and 13 were calls, valued at $1,446,455.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $85.0 to $140.0 for PDD Holdings over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for PDD Holdings's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across PDD Holdings's significant trades, within a strike price range of $85.0 to $140.0, over the past month.
<h3>PDD Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727274657_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$5.75</td>
<td>$5.6</td>
<td>$5.7</td>
<td>$115.00</td>
<td>$570.0K</td>
<td>14.6K</td>
<td style="text-align: right;">792</td>
</tr>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$25.55</td>
<td>$24.1</td>
<td>$24.74</td>
<td>$90.00</td>
<td>$247.4K</td>
<td>916</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$19.55</td>
<td>$18.9</td>
<td>$19.55</td>
<td>$105.00</td>
<td>$144.6K</td>
<td>905</td>
<td style="text-align: right;">88</td>
</tr>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$4.35</td>
<td>$4.15</td>
<td>$4.3</td>
<td>$112.00</td>
<td>$140.1K</td>
<td>941</td>
<td style="text-align: right;">361</td>
</tr>
<tr>
<td>PDD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$29.25</td>
<td>$29.15</td>
<td>$29.15</td>
<td>$140.00</td>
<td>$139.9K</td>
<td>319</td>
<td style="text-align: right;">50</td>
</tr>
</tbody>
</table>

<h3>About PDD Holdings</h3>
PDD Holdings is a multinational commerce group that owns and operates a portfolio of businesses. PDD aims to bring more businesses and people into the digital economy so that local communities and small businesses can benefit from the increased productivity and new opportunities. PDD has built a network of sourcing, logistics, and fulfillment capabilities that support its underlying businesses.
<h3>Current Position of PDD Holdings</h3>
<ul>
<li>With a volume of 4,364,295, the price of PDD is down -1.62% at $111.96. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 62 days.</li>
</ul>
<h3>Expert Opinions on PDD Holdings</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $160.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Bernstein persists with their Outperform rating on PDD Holdings, maintaining a target price of $170. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for PDD Holdings, targeting a price of $170. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for PDD Holdings, targeting a price of $158. 
&#x2A; Reflecting concerns, an analyst from Citigroup lowers its rating to Neutral with a new price target of $120. 
&#x2A; Maintaining their stance, an analyst from Benchmark continues to hold a Buy rating for PDD Holdings, targeting a price of $185. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for PDD Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PDD Holdings's Options Frenzy: What You Need to Know

Whales with a lot of money to spend have taken a noticeably bearish stance on Dell Technologies.
Looking at options history for Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 30% of the investors opened trades with bullish expectations and 60% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $298,962 and 4, calls, for a total amount of $166,580.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $80.0 to $140.0 for Dell Technologies over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Dell Technologies stands at 1142.5, with a total volume reaching 744.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Dell Technologies, situated within the strike price corridor from $80.0 to $140.0, throughout the last 30 days.
<h3>Dell Technologies Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727274652_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DELL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$42.65</td>
<td>$42.2</td>
<td>$42.65</td>
<td>$80.00</td>
<td>$72.5K</td>
<td>140</td>
<td style="text-align: right;">17</td>
</tr>
<tr>
<td>DELL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/11/24</td>
<td>$4.45</td>
<td>$3.65</td>
<td>$4.04</td>
<td>$119.00</td>
<td>$67.8K</td>
<td>918</td>
<td style="text-align: right;">171</td>
</tr>
<tr>
<td>DELL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$10.55</td>
<td>$10.4</td>
<td>$10.55</td>
<td>$120.00</td>
<td>$64.3K</td>
<td>1.1K</td>
<td style="text-align: right;">63</td>
</tr>
<tr>
<td>DELL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$10.75</td>
<td>$10.75</td>
<td>$10.75</td>
<td>$125.00</td>
<td>$50.3K</td>
<td>385</td>
<td style="text-align: right;">144</td>
</tr>
<tr>
<td>DELL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$8.65</td>
<td>$8.2</td>
<td>$8.27</td>
<td>$125.00</td>
<td>$48.0K</td>
<td>3.6K</td>
<td style="text-align: right;">64</td>
</tr>
</tbody>
</table>

<h3>About Dell Technologies</h3>
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It is focused on premium and commercial personal computers and enterprise on-premises data center hardware. It holds top-three market shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners, and also relies heavily on channel partners to fulfill its sales.
Following our analysis of the options activities associated with Dell Technologies, we pivot to a closer look at the company's own performance.
<h3>Where Is Dell Technologies Standing Right Now?</h3>
<ul>
<li>With a trading volume of 1,491,896, the price of DELL is up by 1.59%, reaching $119.18.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 62 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Dell Technologies</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $147.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Evercore ISI Group continues to hold a Outperform rating for Dell Technologies, targeting a price of $140. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Dell Technologies with a target price of $158. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Dell Technologies, maintaining a target price of $140. 
&#x2A; An analyst from Citigroup persists with their Buy rating on Dell Technologies, maintaining a target price of $160. 
&#x2A; An analyst from Bernstein persists with their Outperform rating on Dell Technologies, maintaining a target price of $140. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Dell Technologies with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

DELL

Market Whales and Their Recent Bets on DELL Options

High-rolling investors have positioned themselves bullish on Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in SNOW often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 13 options trades for Snowflake. This is not a typical pattern.
The sentiment among these major traders is split, with 69% bullish and 30% bearish. Among all the options we identified, there was one put, amounting to $35,100, and 12 calls, totaling $516,100.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $111.0 to $135.0 for Snowflake over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Snowflake's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Snowflake's significant trades, within a strike price range of $111.0 to $135.0, over the past month.
<h3>Snowflake Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727274646_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/27/24</td>
<td>$3.95</td>
<td>$2.99</td>
<td>$3.61</td>
<td>$111.00</td>
<td>$90.2K</td>
<td>1.3K</td>
<td style="text-align: right;">261</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/27/24</td>
<td>$4.5</td>
<td>$4.35</td>
<td>$4.35</td>
<td>$111.00</td>
<td>$53.0K</td>
<td>1.3K</td>
<td style="text-align: right;">751</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$5.05</td>
<td>$4.95</td>
<td>$5.05</td>
<td>$135.00</td>
<td>$50.5K</td>
<td>1.4K</td>
<td style="text-align: right;">207</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$5.1</td>
<td>$4.95</td>
<td>$5.05</td>
<td>$135.00</td>
<td>$50.4K</td>
<td>1.4K</td>
<td style="text-align: right;">107</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/11/24</td>
<td>$4.3</td>
<td>$4.25</td>
<td>$4.25</td>
<td>$115.00</td>
<td>$42.5K</td>
<td>337</td>
<td style="text-align: right;">111</td>
</tr>
</tbody>
</table>

<h3>About Snowflake</h3>
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers, including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
In light of the recent options history for Snowflake, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Snowflake Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 10,539,416, with SNOW's price up by 2.43%, positioned at $115.23.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 63 days.</li>
</ul>
<h3>What The Experts Say On Snowflake</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $125.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on Snowflake with a target price of $125. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Snowflake options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

SNOW

Snowflake Unusual Options Activity For September 25

Cardiff Lexington Corporation reports Q2 results

Cardiff Lexington announces reduction of convertible debt balance

Cardiff Lexington appoints Matthew Shafer as CFO

Cardiff Lexington reports Q4 results

IPO Roundup: UL Solutions, PACS Group, and more

Cardiff Lexington (CDIX) has issued an announcement. Cardiff Lexington Corporation has announced a restructuring of its accounting department, resu...

Cardiff Lexington Restructures Accounting, Changes Leadership

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Cardiff Lexington

News

Latest news for Cardiff Lexington (OTC:CDIX) Stock

Monday, August 05, 2019